Financials in USD. Standardized financial statements.
A compact view of how BioInvent International AB (publ) turns revenue into operating income and net income.
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue? | $225.93M | $44.69M | $71.46M | $326.13M | $19.38M | $147.37M | $93.74M | $38.55M | $45.01M | $71.28M |
| Revenue Growth? | +405.6% | -37.5% | -78.1% | +1582.4% | -86.8% | +57.2% | +143.2% | -14.4% | -36.9% | 0.0% |
| Cost of Revenue? | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $2.88M | $996,000 |
| Gross Profit? | $226.50M | $44.69M | $71.46M | $326.13M | $19.38M | $147.37M | $93.74M | $38.55M | $42.13M | $70.29M |
| Gross Margin? | +100.3% | +100.0% | +100.0% | +100.0% | +100.0% | +100.0% | +100.0% | +100.0% | +93.6% | +98.6% |
| Operating Expenses? | $578.18M | $515.75M | $441.40M | $376.60M | $297.55M | $222.33M | $230.74M | $161.63M | $147.37M | $134.52M |
| Operating Income? | -$350.51M | -$471.06M | -$369.94M | -$50.92M | -$278.35M | -$75.47M | -$137.85M | -$123.23M | -$100.63M | -$62.86M |
| EBITDA? | -$330.69M | -$460.01M | -$312.71M | -$27.13M | -$263.32M | -$63.99M | -$126.54M | -$118.10M | -$97.65M | -$61.59M |
| Income Before Tax | -$331.63M | -$429.24M | -$330.10M | -$42.50M | -$278.44M | -$76.33M | -$138.63M | -$123.16M | -$100.53M | -$62.59M |
| Income Tax Expense | $396,000 | $135,000 | $204,000 | $0 | $0 | $0 | $0 | -$72,000 | $86,000 | $159,000 |
| Net Income? | -$332.02M | -$429.38M | -$330.30M | -$34.09M | -$278.96M | -$76.67M | -$139.12M | -$123.16M | -$100.53M | -$62.59M |
| EPS? | $-5.07 | $-6.53 | $-5.02 | $-0.55 | $-5.15 | $-2.67 | $-7.53 | $-9.07 | $-8.08 | $-6.18 |
| Diluted EPS? | $-5.07 | $-6.53 | $-5.02 | $-0.55 | $-5.15 | $-2.67 | $-7.53 | $-8.91 | $-8.08 | $-6.18 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality